Aman Saini

Aman Saini

Auto-generated profile, based on publicly available information

Aman Saini

Department of Neurology, King’s College Hospital, London

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2019 in Abdominal Radiology
Verified
Journal Article
Closed access
SASadeer J. Alzubaidi
Sadeer J. Alzubaidi
IPIndravadan J Patel
Indravadan J Patel
ASAman Saini
Aman Saini
GKGrace Knuttinen
Grace Knuttinen
SNSailendra Naidu
Sailendra Naidu
RORahmi Oklu
Rahmi Oklu

3 November 2026 in The Journal of Neuropsychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
ASAman Saini
Aman Saini
EKEric Kelleher
Eric Kelleher
EBElla Burchill
Ella Burchill
HCHarry Costello
Harry Costello
EJEileen Joyce
Eileen Joyce
MZMichael S. Zandi
Michael S. Zandi

1 June 2026 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
ASAman Saini
Aman Saini
AAAdemola Adeyeye
Ademola Adeyeye
HGHao Gao
Hao Gao
MSMolly Steele
Molly Steele
AJAlisha Jafri
Alisha Jafri
AHAmyn Haji
Amyn Haji
Background: A substantial proportion of colorectal cancer (CRC) patients are managed without curative intent due to frailty, comorbidity, or patient choice. Outcomes in this heterogeneous population remain incompletely characterised. We evaluated survival and treatment patterns in patients managed non-curatively, including exploratory analyses by tumour sidedness and metastatic status. Methods: We conducted a retrospective cohort study of patients diagnosed with CRC at King’s College Hospital, London, between 2013 and 2022. Patients with histologically or radiologically confirmed CRC discussed at the multidisciplinary team (MDT) meeting were included; those receiving curative-intent treatment were excluded. Baseline variables included Eastern Cooperative Oncology Group (ECOG) performance status, tumour location, and metastatic disease at diagnosis. Overall survival (OS) from diagnosis was analysed using Kaplan-Meier methods and multivariable Cox regression. Results: Of 1,501 patients with CRC, 267 (18%) were managed non-curatively. Mean age was 74.7 years, and 60.3% were male; 59.9% were ECOG 0–2. Chemotherapy (28%) and surgery (15.7%) were the most frequent treatments. 5.2% required emergency surgery. Median OS was 210 days [95% confidence interval (CI): 205–210]. On multivariable analysis, ECOG ≥3 [hazard ratio (HR) 2.40, 95% CI: 1.42–4.05; P=0.001] and metastatic disease (HR 2.36, 95% CI: 1.41–3.94; P=0.001) were independently associated with worse OS. Tumour sidedness was not associated with survival (HR 1.00, 95% CI: 0.62–1.61; P=0.99). Conclusions: Patients with CRC managed non-curatively are often ambulant and may continue to receive supportive interventions aimed at maintaining quality of life. These findings support individualised risk stratification and prospective evaluation incorporating frailty and quality-of-life measures.